Skip to Content
Merck

Skip To

EM0200

Osteo-Bed Bone Embedding Kit

Sign In to View Organizational & Contract Pricing.

About This Item

NACRES:
NA.47
UNSPSC Code:
12171500
Storage temp.:
room temp


application(s)

hematology
histology

storage temp.

room temp

Application

Suitable for use with large and small mineralized (undecalcified) bone sections. Yields clear, hard blocks for cutting sections. Not water-soluble.

Other Notes

Osteo-Bed Bone Embedding Solvent (O8639) is available to remove plastic from sections.


Kit Components Only

Product No.
Description

  • Osteo-Bed Bone Embedding Resin A (O8514) 900 mL

  • Osteo-Bed Bone Embedding Catalyst (O8764) 2 x 12

signalword

Danger

target_organs

Respiratory system

Storage Class

5.2 - Organic peroxides and self-reacting hazardous materials

flash_point_f

50.0 °F

flash_point_c

10 °C

Hazard Classifications

Aquatic Acute 1 - Aquatic Chronic 1 - ED ENV 1 - ED HH 1 - Eye Irrit. 2 - Flam. Liq. 2 - Org. Perox. D - Repr. 1B - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library


Related Content


Lei Qin et al.
Journal of orthopaedic translation, 34, 60-72 (2022-05-27)
The key focal adhesion protein β1 integrin plays an essential role in early skeletal development. However, roles of β1 integrin expression in osteocytes during the regulation of bone homeostasis and mechanotransduction are incompletely understood. To study the in vivo function
Nur-Vaizura Mohamad et al.
International journal of medical sciences, 18(16), 3665-3673 (2021-11-19)
Menopause is the leading cause of osteoporosis for elderly women due to imbalanced bone remodelling in the absence of oestrogen. The ability of tocotrienol in reversing established bone loss due to oestrogen deficiency remains unclear despite the plenitude of evidence
Colin K Yee et al.
Clinical & experimental metastasis, 25(8), 903-911 (2008-09-25)
In the current study, we examine heparin's anti-metastatic properties by using a well-defined mouse model of osteolytic bone metastasis. C57BL/6 mice were treated with increasing doses of unfractionated heparin (15, 20, or 25 units/mouse) 30 min prior to the left



Global Trade Item Number

SKUGTIN
EM0200-1KT04061833609439

Questions

Reviews

No rating value

Active Filters